Mosapramine

DB13676ExperimentalSmall molecule

Mosapramine: Overview.

Mechanism: Pharmacologically active on Dopamine receptor D3 and Dopamine receptor D2
Curator reviewed
Formula / weight: C₂₈H₃₅ClN₄O · 479.07 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyPXUIZULXJVRBPC-UHFFFAOYSA-NSMILESClC1=CC2=C(CCC3=CC=CC=C3N2CCCN2CCC3(CC2)N2CCCCC2NC3=O)C=C1

Targets

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

718Drug interactionsStructured to mechanism, not free text

1ATC codeIncluding every combination product, plus 6 drug categories

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Mosapramine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.